Home › Asset managers › Guggenheim › 2024-2025 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Guggenheim voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
2,496 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Guggenheim voted | Funds |
|---|---|---|---|---|---|---|---|
| 1-800-FLOWERS.COM, Inc. | December 11, 2024 | Election of Directors: Larry Zarin | Director Elections | Board | WITHHOLD | 5 | |
| 1-800-FLOWERS.COM, Inc. | December 11, 2024 | Election of Directors: Leonard J. Elmore | Director Elections | Board | WITHHOLD | 5 | |
| 1-800-FLOWERS.COM, Inc. | December 11, 2024 | Election of Directors: Stephanie Redish Hofmann | Director Elections | Board | WITHHOLD | 5 | |
| 3D Systems Corporation | August 30, 2024 | The approval of the amendment and restatement of the 2015 Incentive Plan that, among other things, increases the number of shares reserved for issuance thereunder by 4,000,000 shares; and | Compensation | Board | AGAINST | 5 | |
| 3D Systems Corporation | August 30, 2024 | The election of the nine directors named in the accompanying Proxy Statement: Claudia N. Drayton | Director Elections | Board | AGAINST | 5 | |
| 3D Systems Corporation | August 30, 2024 | The election of the nine directors named in the accompanying Proxy Statement: Kevin S. Moore | Director Elections | Board | AGAINST | 5 | |
| 3D Systems Corporation | August 30, 2024 | The election of the nine directors named in the accompanying Proxy Statement: Vasant Padmanabhan | Director Elections | Board | AGAINST | 5 | |
| 3D Systems Corporation | May 16, 2025 | The election of the nine directors named in the accompanying Proxy Statement: Claudia N. Drayton | Director Elections | Board | AGAINST | 5 | |
| 3D Systems Corporation | May 16, 2025 | The election of the nine directors named in the accompanying Proxy Statement: Kevin S. Moore | Director Elections | Board | AGAINST | 5 | |
| 3D Systems Corporation | May 16, 2025 | The election of the nine directors named in the accompanying Proxy Statement: Thomas W. Erickson | Director Elections | Board | AGAINST | 5 | |
| 8x8, Inc. | August 15, 2024 | To approve an amendment to the 2022 Equity Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 14,000,000 shares. | Compensation | Board | AGAINST | 5 | |
| ALX Oncology Holdings Inc. | June 11, 2025 | Election of Directors: Scott Garland | Director Elections | Board | WITHHOLD | 5 | |
| Accolade, Inc. | August 6, 2024 | Election of Directors: Cindy Kent | Director Elections | Board | WITHHOLD | 5 | |
| Aeva Technologies, Inc. | June 20, 2025 | Election of Class I Directors: Stefan Sommer, Ph. D. | Director Elections | Board | WITHHOLD | 5 | |
| Alector, Inc. | June 11, 2025 | ELECTION OF DIRECTORS: Paula Hammond, Ph.D. | Director Elections | Board | WITHHOLD | 5 | |
| Allogene Therapeutics, Inc. | June 18, 2025 | Election of Directors: Arie Belldegrun, M.D. | Director Elections | Board | WITHHOLD | 5 | |
| Allogene Therapeutics, Inc. | June 18, 2025 | Election of Directors: David Chang, M.D., Ph.D. | Director Elections | Board | WITHHOLD | 5 | |
| Allogene Therapeutics, Inc. | June 18, 2025 | Election of Directors: Elizabeth Barrett | Director Elections | Board | WITHHOLD | 5 | |
| Applied Therapeutics, Inc. | June 9, 2025 | Election of Director: Teena Lerner | Director Elections | Board | AGAINST | 5 | |
| Arvinas, Inc. | June 25, 2025 | Election of three Class I directors: John Houston, Ph.D. | Director Elections | Board | WITHHOLD | 5 | |
| Arvinas, Inc. | June 25, 2025 | Election of three Class I directors: Laurie Smaldone Alsup, M.D. | Director Elections | Board | WITHHOLD | 5 | |
| Arvinas, Inc. | June 25, 2025 | Election of three Class I directors: Linda Bain | Director Elections | Board | WITHHOLD | 5 | |
| Beyond, Inc. | May 15, 2025 | The approval of an amendment and restatement of the Company's Amended and Restated 2005 Equity Incentive Plan (the "2005 Plan"). | Compensation | Board | AGAINST | 5 | |
| BioLife Solutions, Inc. | August 1, 2024 | Election of Directors: Joydeep Goswami | Director Elections | Board | WITHHOLD | 5 | |
| BioLife Solutions, Inc. | August 1, 2024 | Election of Directors: Rachel Ellingson | Director Elections | Board | WITHHOLD | 5 | |
| Boston Omaha Corporation | September 20, 2024 | Election of Directors (other than the Class B common stock Director): Frank H. Kenan II | Director Elections | Board | WITHHOLD | 5 | |
| Boston Omaha Corporation | September 20, 2024 | Election of Directors (other than the Class B common stock Director): Jeffrey C. Royal | Director Elections | Board | WITHHOLD | 5 | |
| Boston Omaha Corporation | September 20, 2024 | Election of Directors (other than the Class B common stock Director): Vishnu Srinivasan | Director Elections | Board | WITHHOLD | 5 | |
| Canoo Inc. | December 6, 2024 | Election of Directors: Debra von Storch | Director Elections | Board | WITHHOLD | 5 | |
| Canoo Inc. | December 6, 2024 | Election of Directors: Foster Chiang | Director Elections | Board | WITHHOLD | 5 | |
| Canoo Inc. | December 6, 2024 | To approve an amendment to our 2020 Equity Incentive Plan (the "2020 EIP") to increase the number of shares of our Common Stock available and reserved for issuance under the 2020 EIP by an additional 45,000,000 shares of Common Stock. | Compensation | Board | AGAINST | 5 | |
| Cardlytics, Inc. | May 20, 2025 | Approval of the Cardlytics, Inc. 2025 Equity Incentive Plan. | Compensation | Board | AGAINST | 5 | |
| Cardlytics, Inc. | May 20, 2025 | Election of Directors: Alex Mishurov | Director Elections | Board | WITHHOLD | 5 | |
| Cartesian Therapeutics, Inc. | June 13, 2025 | Election of Directors: Timothy C. Barabe, MBA | Director Elections | Board | WITHHOLD | 5 | |
| Century Therapeutics, Inc. | June 12, 2025 | Election of Class I directors for a three year term expiring in 2028: Carlo Rizzuto, Ph.D. | Director Elections | Board | WITHHOLD | 5 | |
| Century Therapeutics, Inc. | June 12, 2025 | Election of Class I directors for a three year term expiring in 2028: Daphne Quimi | Director Elections | Board | WITHHOLD | 5 | |
| Cerus Corporation | June 3, 2025 | The approval of an amendment and restatement of the Company's 2024 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 10 million shares and to make certain other changes thereto as described further in the accompanying Proxy Statement. | Compensation | Board | AGAINST | 5 | |
| Cimpress Plc | November 20, 2024 | Amend Cimpress' 2020 Equity Incentive Plan to increase the number of ordinary shares issuable under the plan. | Compensation | Board | AGAINST | 5 | |
| Cimpress Plc | November 20, 2024 | Reappoint Dessislava Temperley to Cimpress' Board of Directors to serve for a term of three years. | Director Elections | Board | AGAINST | 5 | |
| Climb Bio, Inc. | June 4, 2025 | The election of two directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his or her respective successor has been duly elected and qualified: Judith Dunn, Ph.D. | Director Elections | Board | WITHHOLD | 5 | |
| Danimer Scientific, Inc. | July 9, 2024 | Approval of an amendment to the Company's 2020 Long-Term Incentive Plan. | Compensation | Board | AGAINST | 5 | |
| Danimer Scientific, Inc. | July 9, 2024 | Election of Directors: Allison M. Leopold Tilley | Director Elections | Board | WITHHOLD | 5 | |
| Danimer Scientific, Inc. | July 9, 2024 | Election of Directors: John P. Amboian | Director Elections | Board | WITHHOLD | 5 | |
| Danimer Scientific, Inc. | July 9, 2024 | Election of Directors: Philip Gregory Calhoun | Director Elections | Board | WITHHOLD | 5 | |
| Douglas Elliman Inc. | August 21, 2024 | Election of Directors: Howard M. Lorber | Director Elections | Board | WITHHOLD | 5 | |
| Editas Medicine, Inc. | May 29, 2025 | To approve an amendment and restatement of the Company's 2015 Stock Incentive Plan. | Compensation | Board | AGAINST | 5 | |
| FIGS, Inc. | June 4, 2025 | Election of Directors: Catherine Spear | Director Elections | Board | WITHHOLD | 5 | |
| FIGS, Inc. | June 4, 2025 | Election of Directors: Sheila Antrum | Director Elections | Board | WITHHOLD | 5 | |
| Fate Therapeutics, Inc. | May 29, 2025 | To approve the amendment and restatement of the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. | Compensation | Board | AGAINST | 5 | |
| Fortive Corporation | June 3, 2025 | To approve the amendment and restatement of the 2016 Stock Incentive Plan to extend the term of the plan. | Compensation | Board | AGAINST | 5 | |
| GoPro, Inc. | June 3, 2025 | Election of Directors: Nicholas Woodman | Director Elections | Board | WITHHOLD | 5 | |
| GoPro, Inc. | June 3, 2025 | Election of Directors: Shaz Kahng | Director Elections | Board | WITHHOLD | 5 | |
| GoPro, Inc. | June 3, 2025 | Election of Directors: Susan Lyne | Director Elections | Board | WITHHOLD | 5 | |
| GoPro, Inc. | June 3, 2025 | Election of Directors: Tyrone Ahmad-Taylor | Director Elections | Board | WITHHOLD | 5 | |
| Greenwich LifeSciences, Inc. | December 19, 2024 | Election of Directors Nominees: David B. McWilliams | Director Elections | Board | WITHHOLD | 5 | |
| Greenwich LifeSciences, Inc. | December 19, 2024 | Election of Directors Nominees: Eric Rothe | Director Elections | Board | WITHHOLD | 5 | |
| Greenwich LifeSciences, Inc. | December 19, 2024 | Election of Directors Nominees: F. Joseph Daugherty, M.D. | Director Elections | Board | WITHHOLD | 5 | |
| Greenwich LifeSciences, Inc. | December 19, 2024 | Election of Directors Nominees: Kenneth Hallock | Director Elections | Board | WITHHOLD | 5 | |
| Greenwich LifeSciences, Inc. | December 19, 2024 | Election of Directors Nominees: Snehal S. Patel | Director Elections | Board | WITHHOLD | 5 | |
| Greenwich LifeSciences, Inc. | December 19, 2024 | Proposal to approve an amendment to the Greenwich Life Sciences, Inc. 2019 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance under such plan to 4,000,000 shares from 1,500,000 shares. | Compensation | Board | AGAINST | 5 | |
| GrowGeneration Corp. | June 19, 2025 | Election of Directors: Eula Adams | Director Elections | Board | WITHHOLD | 5 | |
| GrowGeneration Corp. | June 19, 2025 | Election of Directors: Stephen Aiello | Director Elections | Board | WITHHOLD | 5 | |
| Hilltop Holdings, Inc. | July 25, 2024 | Election of Directors: W. Robert Nichols, III | Director Elections | Board | WITHHOLD | 5 | |
| Hyliion Holdings Corp. | May 20, 2025 | Election of Directors: Jeffrey Craig | Director Elections | Board | WITHHOLD | 5 | |
| Kodiak Sciences Inc. | June 2, 2025 | Elect two Class I directors nominated by our board and named in this proxy statement: Richard S. Levy, M.D. | Director Elections | Board | WITHHOLD | 5 | |
| Lexicon Pharmaceuticals, Inc. | June 2, 2025 | Ratification and approval of the amendment to the Company's 2017 Equity Incentive Plan | Compensation | Board | AGAINST | 5 | |
| Lineage Cell Therapeutics, Inc. | June 26, 2025 | To approve an amendment to the Lineage Cell Therapeutics, Inc. 2021 Equity Incentive Plan to increase the number of common shares available thereunder by 19,500,000. | Compensation | Board | AGAINST | 5 | |
| Neurogene, Inc. | June 12, 2025 | Election of Class II Directors for terms expiring in 2028: Robert Keith Woods | Director Elections | Board | WITHHOLD | 5 | |
| Neurogene, Inc. | June 12, 2025 | To approve an amendment to our 2023 Employee Stock Purchase Plan to clarify that the number of outstanding shares of common stock used to calculate the automatic share reserve increase includes shares issuable on exercise of prefunded warrants and conversion of preferred stock. | Compensation | Board | AGAINST | 5 | |
| Neurogene, Inc. | June 12, 2025 | To approve an amendment to our 2023 Equity Incentive Plan to clarify that the number of outstanding shares of common stock used to calculate the automatic share reserve increase includes shares issuable on exercise of prefunded warrants and conversion of preferred stock. | Compensation | Board | AGAINST | 5 | |
| Newmark Group, Inc. | October 17, 2024 | Approval of the Amended and Restated Newmark Group, Inc. Long Term Incentive Plan. | Compensation | Board | AGAINST | 5 | |
| Newmark Group, Inc. | October 17, 2024 | Election of Directors: Howard W. Lutnick | Director Elections | Board | WITHHOLD | 5 | |
| Newmark Group, Inc. | October 17, 2024 | Election of Directors: Kenneth A. McIntyre | Director Elections | Board | WITHHOLD | 5 | |
| Newmark Group, Inc. | October 17, 2024 | Election of Directors: Virginia S. Bauer | Director Elections | Board | WITHHOLD | 5 | |
| Nuvation Bio Inc. | May 21, 2025 | Election of Director: Kathryn E. Falberg | Director Elections | Board | WITHHOLD | 5 | |
| Ouster, Inc. | June 18, 2025 | Election of Class I Directors: Ernest E. Maddock | Director Elections | Board | WITHHOLD | 5 | |
| Pacific Biosciences of California, Inc. | June 4, 2025 | To approve the amendment of our 2020 Equity Incentive Plan. | Compensation | Board | AGAINST | 5 | |
| Pioneer Bancorp, Inc. | November 19, 2024 | Election of Directors: Shaun Mahoney | Director Elections | Board | WITHHOLD | 5 | |
| Precigen, Inc. | July 5, 2024 | Company Proposal - Election of Directors: Steven Frank | Director Elections | Board | AGAINST | 5 | |
| Precigen, Inc. | June 26, 2025 | Company Proposal - Approval, in compliance with Nasdaq Listing Rule 5635(c), of the additional issuance of shares of Series A Preferred Stock and Warrants to Randal J. Kirk as PIK dividends, in order for Mr. Kirk to receive PIK dividends on the Series A Preferred Stock on the same terms as the other investors. | Capital Structure | Board | AGAINST | 5 | |
| Precigen, Inc. | June 26, 2025 | Company Proposal - Election of Directors: Cesar Alvarez | Director Elections | Board | AGAINST | 5 | |
| Prelude Therapeutics Incorporated | June 12, 2025 | Election of Class II Directors: Victor Sandor, M.D.C.M. | Director Elections | Board | WITHHOLD | 5 | |
| Pyxis Oncology, Inc. | October 23, 2024 | Approval of an increase in the number of shares of our common stock available for issuance under our 2021 Equity and Incentive Plan by 5,500,000 shares. | Compensation | Board | AGAINST | 5 | |
| Pyxis Oncology, Inc. | June 18, 2025 | The election of Class I directors named in the proxy statement: Darren Cline | Director Elections | Board | WITHHOLD | 5 | |
| Pyxis Oncology, Inc. | June 18, 2025 | The election of Class I directors named in the proxy statement: Rachel Humphrey, M.D. | Director Elections | Board | WITHHOLD | 5 | |
| Pyxis Oncology, Inc. | June 18, 2025 | The election of Class I directors named in the proxy statement: Santhosh Palani, Ph.D., CFA | Director Elections | Board | WITHHOLD | 5 | |
| Rackspace Technology, Inc. | June 20, 2025 | Election of Directors: Mitchell Garber | Director Elections | Board | WITHHOLD | 5 | |
| Replimune Group, Inc. | September 4, 2024 | Election of Directors: Dieter Weinand | Director Elections | Board | WITHHOLD | 5 | |
| Sleep Number Corporation | May 28, 2025 | Approve Amendment to the Sleep Number Corporation 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by 500,000 shares | Compensation | Board | AGAINST | 5 | |
| Smith & Wesson Brands, Inc. | September 17, 2024 | A stockholder proposal (human rights impact assessment); | Human Rights or Human Capital/workforce | Shareholder | Against | FOR | 5 |
| Solid Biosciences Inc. | June 12, 2025 | Election of Class I Directors: Alexander Cumbo | Director Elections | Board | WITHHOLD | 5 | |
| Solid Biosciences Inc. | June 12, 2025 | Election of Class I Directors: Sukumar Nagendran | Director Elections | Board | WITHHOLD | 5 | |
| Solid Biosciences Inc. | June 12, 2025 | The approval of an amendment to the Company's Amended and Restated 2020 Equity Incentive Plan to increase the number of shares of our common stock available for issuance thereunder by 9,000,000 shares and amend the evergreen provision. | Compensation | Board | AGAINST | 5 | |
| Solo Brands, Inc. | May 23, 2025 | Election of Directors: Andrea K. Tarbox | Director Elections | Board | WITHHOLD | 5 | |
| Standard BioTools Inc. | June 18, 2025 | To approve an amendment to our Amended and Restated 2011 Equity Incentive Plan, as amended, to increase the number of shares of common stock available for issuance thereunder by 17,400,000 shares. | Compensation | Board | AGAINST | 5 | |
| Star Holdings | May 21, 2025 | Election of Trustees: Clifford De Souza | Director Elections | Board | WITHHOLD | 5 | |
| Star Holdings | May 21, 2025 | Election of Trustees: Nina Matis | Director Elections | Board | WITHHOLD | 5 | |
| Star Holdings | May 21, 2025 | Election of Trustees: Richard Lieb | Director Elections | Board | WITHHOLD | 5 | |
| Stem, Inc. | June 4, 2025 | To approve an amendment and restatement of the Stem, Inc. 2024 Equity Incentive Plan to increase the number of shares available for issuance by 7,500,000 shares and to extend the plan term. | Compensation | Board | AGAINST | 5 | |
| Stitch Fix, Inc. | December 12, 2024 | Election of Directors: Sharon McCollam | Director Elections | Board | WITHHOLD | 5 |
← Previous Page 7 of 25 Next →
← Back to Guggenheim 2024-2025 overview
Built October 25, 2026 from SEC Form N-PX filings.